ALLOGENE THERAPEUTICS Trademark

Trademark Overview

On Friday, September 28, 2018, a trademark application was filed for ALLOGENE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ALLOGENE THERAPEUTICS trademark a serial number of 88136825. The federal status of this trademark filing is REGISTERED as of Tuesday, June 1, 2021. This trademark is owned by Allogene Therapeutics, Inc.. The ALLOGENE THERAPEUTICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment

General Information

Serial Number88136825
Word MarkALLOGENE THERAPEUTICS
Filing DateFriday, September 28, 2018
Status700 - REGISTERED
Status DateTuesday, June 1, 2021
Registration Number6373409
Registration DateTuesday, June 1, 2021
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesProviding medical information to patients and medical professionals in the form of reports in the field of immunotherapy and cancer treatment
Description of MarkThe mark consists of the words "ALLOGENE THERAPEUTICS" next to a dotted circle design.

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, October 7, 2018
Primary Code044
First Use Anywhere DateSaturday, December 5, 2020
First Use In Commerce DateSaturday, December 5, 2020

Trademark Owner History

Party NameAllogene Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameAllogene Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US
Party NameAllogene Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
US

Trademark Events

Event DateEvent Description
Tuesday, October 2, 2018NEW APPLICATION ENTERED
Sunday, October 7, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 9, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 26, 2018ASSIGNED TO EXAMINER
Tuesday, January 1, 2019EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 1, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 1, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, January 1, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 18, 2019ASSIGNED TO LIE
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 22, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019SOU EXTENSION 1 FILED
Tuesday, October 22, 2019SOU EXTENSION 1 GRANTED
Thursday, October 24, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 31, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, March 31, 2020SOU EXTENSION 2 FILED
Tuesday, March 31, 2020SOU EXTENSION 2 GRANTED
Thursday, April 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 18, 2020SOU TEAS EXTENSION RECEIVED
Friday, September 18, 2020SOU EXTENSION 3 FILED
Friday, September 18, 2020SOU EXTENSION 3 GRANTED
Tuesday, September 22, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 7, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, April 7, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, April 21, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 7, 2021SOU EXTENSION 4 FILED
Wednesday, April 21, 2021SOU EXTENSION 4 GRANTED
Wednesday, April 7, 2021USE AMENDMENT FILED
Wednesday, April 21, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 27, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, April 28, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 1, 2021REGISTERED-PRINCIPAL REGISTER
Friday, February 28, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 28, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 28, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 28, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, June 1, 2026COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

therapeutics allogene medical field immunotherapy treatment reports cancer form information patients professionals